Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management

MZ Handler, PA Patel, R Kapila, Y Al-Qubati… - Journal of the American …, 2015 - Elsevier
The diagnosis of leishmaniasis can be challenging because it mimics both infectious and
malignant conditions. A misdiagnosis may lead to an unfavorable outcome. Using culture …

Treatment of cutaneous leishmaniasis and insights into species-specific responses: a narrative review

RK Madusanka, H Silva, ND Karunaweera - Infectious diseases and …, 2022 - Springer
Cutaneous leishmaniasis (CL) is a complex skin infection that has imposed a heavy burden
on many develo** countries and is caused by more than 20 Leishmania species. This …

Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical …

N Aronson, BL Herwaldt, M Libman… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

Chemical composition of Mentha pulegium and Rosmarinus officinalis essential oils and their antileishmanial, antibacterial and antioxidant activities

A Bouyahya, A Et-Touys, Y Bakri, A Talbaui… - Microbial …, 2017 - Elsevier
The aim of the study was the determination of the chemical composition of Mentha pulegium
L. and Rosmarinus officinalis L. essential oils and the evaluation of their antileishmanial …

[HTML][HTML] Fe3O4@ piroctone olamine magnetic nanoparticles: Synthesize and therapeutic potential in cutaneous leishmaniasis

AE Albalawi, AK Khalaf, MS Alyousif, AD Alanazi… - Biomedicine & …, 2021 - Elsevier
Background In recent years, magnetic nanoparticles (NMP) as novel materials have been
widely used for biomedical, diagnostic and therapeutic purposes like microbial infection …

Current status on prevention and treatment of canine leishmaniasis

RM Reguera, M Moran, Y Perez-Pertejo… - Veterinary …, 2016 - Elsevier
Canine leishmaniasis (CanL) is a parasite-borne disease mainly induced by Leishmania
infantum in the Old World and Leishmania chagasi (infantum) in the New World. CanL is a …

Recent advances in chemotherapeutics for leishmaniasis: importance of the cellular biochemistry of the parasite and its molecular interaction with the host

R Singh, M Kashif, P Srivastava, PP Manna - Pathogens, 2023 - mdpi.com
Leishmaniasis, a category 1 neglected protozoan disease caused by a kinetoplastid
pathogen called Leishmania, is transmitted through dipteran insect vectors (phlebotomine …

Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime®) in Cutaneous Leishmaniasis

AE Albalawi, S Abdel-Shafy, A Khudair Khalaf… - Nanomaterials, 2021 - mdpi.com
Background: In recent years, the focus on nanotechnological methods in medicine,
especially in the treatment of microbial infections, has increased rapidly. Aim: The present …

Antileishmanial drug discovery and development: time to reset the model?

AI Olias-Molero, C de la Fuente, M Cuquerella… - Microorganisms, 2021 - mdpi.com
Leishmaniasis is a vector-borne parasitic disease caused by Leishmania species. The
disease affects humans and animals, particularly dogs, provoking cutaneous …

A review on potential therapeutic targets for the treatment of leishmaniasis

SY Sheikh, F Hassan, D Shukla, S Bala, T Faruqui… - Parasitology …, 2024 - Elsevier
Leishmania, a protozoan parasite, is responsible for the occurrence of leishmaniasis, a
disease that is prevalent in tropical regions. Visceral Leishmaniasis (VL), also known as kala …